Delivery Order SPE2DB20D1047-SPE2DB23FF53V

Award Date 3/22/23
Potential Completion Date 3/23/23
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $12,452.74. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 4, 2025. The contract is not associated with a set-aside designation,...
This federal contract award is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 10, 2024 as a delivery order with a ceiling value of $7,232.91. The contract has a firm fixed price pricing type and an ultimate completion date of December 11, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 19, 2021, with a ceiling value of $8,495.18. The contract is a Delivery Order with a Firm Fixed Price pricing type and a completion date of November 22, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order (DO) valued at $21,688.44 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4566359326 NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, with a period of performance through November 7, 2024. The contract is a Firm Fixed Price (FFP) vehicle with no set-aside designation, indicating open competition....
The Defense Logistics Agency (DLA) awarded a $34,591.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4564312592 NITROFURANTOIN 25 MG/5 ML SUSP 230ML. This contract has an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 indefinite delivery contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $10,479.42, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, with a ceiling value of $6,005.90 and a performance period through February 2, 2024. The contract is a firm fixed-price, delivery order type, with no set-aside designation. AmerisourceBergen holds a larger Indefinite...
The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract is a Delivery Order with a Firm Fixed Price valued at $2,574.74, with a completion date of December 19, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a child of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,607.92, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a firm fixed price and has a period of performance through May 14, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,850.33 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NITROFURANTOIN 25 MG/5 ML SUSP 240ML. This delivery order contract has a completion date of January 29, 2024 and was awarded on January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this contract. Amerisourcebergen Drug Corp is also...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB23FF53V
    Delivery Order

This contract award is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,127.24, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award has a firm fixed price pricing type and a completion date of March 23, 2023. The contract is not designated as a set-aside.

Generated 5/9/25, 10:08 AM